SEI Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $172M | Buy |
1,900,137
+661,136
| +53% | +$55.4M | 0.15% | 124 |
|
|
2026
Q1 | $99.2M | Buy |
1,239,001
+830,341
| +203% | +$68.5M | 0.09% | 230 |
|
|
2025
Q4 | $34.8M | Sell |
408,660
-23,361
| -5% | -$1.92M | 0.03% | 517 |
|
|
2025
Q3 | $33.6M | Buy |
432,021
+19,213
| +5% | +$1.5M | 0.04% | 507 |
|
|
2025
Q2 | $32.3M | Sell |
412,808
-60,628
| -13% | -$4.52M | 0.04% | 495 |
|
|
2025
Q1 | $34.3M | Buy |
473,436
+124,992
| +36% | +$8.95M | 0.04% | 444 |
|
|
2024
Q4 | $25.8M | Buy |
348,444
+108,821
| +45% | +$7.62M | 0.03% | 562 |
|
|
2024
Q3 | $15.8M | Sell |
239,623
-1,315,228
| -85% | -$95.6M | 0.02% | 787 |
|
|
2024
Q2 | $144M | Buy |
1,554,851
+89,132
| +6% | +$7.89M | 0.2% | 93 |
|
|
2024
Q1 | $140M | Buy |
1,465,719
+907,688
| +163% | +$76.2M | 0.21% | 95 |
|
|
2023
Q4 | $42.6M | Buy |
558,031
+54,595
| +11% | +$3.8M | 0.07% | 318 |
|
|
2023
Q3 | $34.9M | Sell |
503,436
-8,392
| -2% | -$674K | 0.06% | 330 |
|
|
2023
Q2 | $48.3M | Sell |
511,828
-3,373
| -0.7% | -$293K | 0.08% | 237 |
|
|
2023
Q1 | $42.6M | Buy |
515,201
+58,717
| +13% | +$4.62M | 0.08% | 277 |
|
|
2022
Q4 | $34.1M | Sell |
456,484
-63,332
| -12% | -$4.88M | 0.08% | 297 |
|
|
2022
Q3 | $43M | Sell |
519,816
-52,822
| -9% | -$5.08M | 0.1% | 223 |
|
|
2022
Q2 | $54.5M | Buy |
572,638
+77,841
| +16% | +$8.06M | 0.12% | 159 |
|
|
2022
Q1 | $58.2M | Buy |
494,797
+18,843
| +4% | +$2.11M | 0.12% | 168 |
|
|
2021
Q4 | $61.7M | Sell |
475,954
-207,822
| -30% | -$24.2M | 0.12% | 184 |
|
|
2021
Q3 | $77.4M | Buy |
683,776
+86,983
| +15% | +$9.93M | 0.16% | 121 |
|
|
2021
Q2 | $61.8M | Buy |
596,793
+48,612
| +9% | +$4.58M | 0.14% | 134 |
|
|
2021
Q1 | $45.9M | Buy |
548,181
+173,911
| +46% | +$14.7M | 0.12% | 164 |
|
|
2020
Q4 | $34.1M | Buy |
374,270
+1,862
| +0.5% | +$154K | 0.09% | 221 |
|
|
2020
Q3 | $29.7M | Buy |
372,408
+32,746
| +10% | +$2.56M | 0.09% | 220 |
|
|
2020
Q2 | $23.5M | Buy |
339,662
+19,091
| +6% | +$1.36M | 0.07% | 266 |
|
|
2020
Q1 | $20.1M | Sell |
320,571
-77,985
| -20% | -$5.62M | 0.07% | 258 |
|
|
2019
Q4 | $31M | Buy |
398,556
+19,986
| +5% | +$1.56M | 0.09% | 209 |
|
|
2019
Q3 | $27.8M | Buy |
378,570
+43,245
| +13% | +$3.04M | 0.07% | 253 |
|
|
2019
Q2 | $20.6M | Sell |
335,325
-31,488
| -9% | -$1.9M | 0.07% | 296 |
|
|
2019
Q1 | $23.4M | Sell |
366,813
-217,377
| -37% | -$12.4M | 0.08% | 255 |
|
|
2018
Q4 | $33.6M | Buy |
584,190
+9,918
| +2% | +$502K | 0.12% | 166 |
|
|
2018
Q3 | $33.3M | Sell |
574,272
-160,335
| -22% | -$7.84M | 0.12% | 160 |
|
|
2018
Q2 | $35.6M | Buy |
734,607
+592,239
| +416% | +$27.6M | 0.12% | 162 |
|
|
2018
Q1 | $6.62M | Sell |
142,368
-508,203
| -78% | -$22.1M | 0.03% | 694 |
|
|
2017
Q4 | $24.4M | Buy |
650,571
+174,150
| +37% | +$6.39M | 0.08% | 264 |
|
|
2017
Q3 | $17.4M | Sell |
476,421
-99,663
| -17% | -$3.8M | 0.06% | 354 |
|
|
2017
Q2 | $22.7M | Sell |
576,084
-87,663
| -13% | -$3.2M | 0.09% | 255 |
|
|
2017
Q1 | $20.8M | Buy |
663,747
+82,962
| +14% | +$2.6M | 0.09% | 248 |
|
|
2016
Q4 | $18.1M | Buy |
580,785
+312,375
| +116% | +$10.1M | 0.09% | 276 |
|
|
2016
Q3 | $10.8M | Buy |
268,410
+17,235
| +7% | +$649K | 0.05% | 431 |
|
|
2016
Q2 | $8.35M | Sell |
251,175
-343,749
| -58% | -$11.8M | 0.05% | 468 |
|
|
2016
Q1 | $17.5M | Sell |
594,924
-45,678
| -7% | -$1.26M | 0.11% | 228 |
|
|
2015
Q4 | $16.9M | Sell |
640,602
-61,320
| -9% | -$1.59M | 0.1% | 245 |
|
|
2015
Q3 | $16.6M | Buy |
701,922
+462,816
| +194% | +$11.2M | 0.15% | 160 |
|
|
2015
Q2 | $5.67M | Buy |
239,106
+23,406
| +11% | +$528K | 0.05% | 424 |
|
|
2015
Q1 | $5.12M | Buy |
215,700
+114,300
| +113% | +$2.56M | 0.04% | 456 |
|
|
2014
Q4 | $2.15M | Buy |
+101,400
| New | +$2.04M | 0.02% | 682 |
|
Other funds holding EW
SEI Investments's EW Position: Q2 2026 in Review
SEI Investments increased its Edwards Lifesciences (EW) stake by 53% in Q2 2026, buying an estimated $55.4M and bringing the position to 1,900,137 shares worth $172M. The position accounts for 0.15% of the portfolio, ranked #124.
SEI Investments first reported a position in EW in Q4 2014 and has held it in 47 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- SEI Investments held 1,900,137 shares of Edwards Lifesciences worth $172M as of Q2 2026.
- SEI Investments bought 661,136 Edwards Lifesciences shares in Q2 2026, an estimated $55.4M.
- Edwards Lifesciences made up 0.15% of SEI Investments's portfolio in Q2 2026, its #124 holding.
- SEI Investments first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 47 quarters since.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.